"Fast Track" Drug Designations Have Begun, FDA's Axelrad Says
Executive Summary
FDA has begun designating products as "fast track" drugs in response to requests from manufacturers, Center for Drug Evaluation & Research Associate Director for Policy Jane Axelrad told the National Consumer Forum in Washington, D.C. March 20.